VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SRTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SRTSSensus Healthcare, Inc.
$2.26$37M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
SRTS logo

Sensus Healthcare, Inc.

SRTS
NASDAQ · Medical Imaging & Radiation
$2.26
At close - Nov 17, 4:00 PM EST - USD
Market Cap$37M
P/E-2.3x
52W High$5.49
Volume217.32K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Sensus Healthcare Faces Severe Revenue Contraction Headwinds

Sensus Healthcare is currently navigating a challenging period of operational deleveraging, characterized by a sharp decline in top-line revenue from $12.6M in 2023Q4 to $3.4M in 2026Q1.

GrowthContracting
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

SRTS price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

5/12 Beats

EPS beat 5 of last 12 quarters

02

Valuation risk

-109% Peers

P/E is 109% below peer median

03

Market leadership

RS 25 · Lag

Laggard (Underperforming 75% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 12

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
SRTS-44.88%
S&P 500 (^GSPC)+7.21%
1-Year Return
SRTS-43.36%
S&P 500 (^GSPC)+10.03%
3-Year Return
SRTS+5.61%
S&P 500 (^GSPC)+54.98%
5-Year Return
SRTS-59.13%
S&P 500 (^GSPC)+52.75%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
-2.3x
Forward P/E
N/A
EV/EBITDA
N/A
FCF YieldCash Flow
N/A

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
-2.3x
28.9x
0th· Low
EV/EBITDA
N/A
22.2x
N/A
Price/FCF
N/A
195.7x
N/A
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$27M-34.3% YoY
Net income FY25
-$8M-216.1% YoY
Free cash flow FY25
$332K+130.0% YoY
Operating margin FY25
-37.5%-56.9 pts YoY
ROIC (FY25)-25.3%
Avg ROIC 5Y17.6%
ROE (TTM)-38.7%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate5/12 (42%)
Revenue Beat Rate8/12 (67%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 12, 2026
-$0.09-63.6%
vs -$0.06
$6M-9.4%
vs $7M
Q3 2026
Aug 13, 2026
-$0.53-324.0%
vs -$0.13
$2M-50.2%
vs $5M
Q2 2026
May 7, 2026
-$0.16-28.0%
vs -$0.13
$3M-36.2%
vs $5M
Q1 2026
Feb 12, 2026
-$0.19-245.5%
vs -$0.06
$5M-40.8%
vs $8M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
MarketBeat·5d ago
What Sensus Healthcare (SRTS) Said on Its Q3 Earnings Call

Sensus Healthcare NASDAQ: SRTS reported lower third-quarter revenue despite shipping more superficial radiation therapy systems, as product mix and the absence of sales to its historically largest customer weighed on the top line.

Seeking Alpha·5d ago
Sensus Healthcare, Inc. (SRTS) Q3 2026 Earnings Call Transcript

Sensus Healthcare, Inc. (SRTS) Q3 2026 Earnings Call Transcript

Business Wire·5d ago
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended September 30, 2026. Highlights included: Revenues of $6.0 million compared with $6.9 million in the third quarter of 2025, reflecting a product mix of lower-priced SRT-100 systems and the absence.

Business Wire·Nov 10, 2026
Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the sale of its 1,000th superficial radiotherapy (SRT) system, representing an important achievement in the Company's commercial development. This sale underscores Sensus' continued efforts to expand access to SRT as a non-invasive treatment option for non-melanoma.

Filtered for Sensus Healthcare, Inc.More Headlines
04

Compare before deciding

Benchmark SRTS against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Sensus Healthcare, Inc. (SRTS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
SRTS logoSRTSSensus Healthcare, Inc.Current
$2.26$37.2M-2.32-34.26%-96.49%-38.65%—
XTLB logoXTLBXTL Biopharmaceuticals Ltd.
$1.62$712.96K-0.10-100%———
STXS logoSTXSStereotaxis, Inc.
$0.88$86.39M-4.0520.28%-70.86%-108.55%—
ARAY logoARAYAccuray Incorporated
$2.44$7.32M-0.49-12.34%-4.41%-36.6%—
ISRG logoISRGIntuitive Surgical, Inc.
$430.53$152.1B51.1920.51%25.54%16.91%—
GKOS logoGKOSGlaukos Corporation
$243.25$14.35B-87.6732.33%-24.6%-24.91%—

Compare SRTS vs Peers

Sensus Healthcare, Inc. (SRTS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XTLB

Most directly comparable listed peer for SRTS.

Scale Benchmark

vs ABT

Larger-name benchmark to compare SRTS against a more recognizable public peer.

Peer Set

Compare Top 5

vs XTLB, STXS, ARAY, ISRG

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

SRTS SEC Filings & Documents

Sensus Healthcare, Inc. (SRTS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 12, 2026·SEC

Material company update

Aug 13, 2026·SEC

Material company update

Jun 5, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 4, 2026·SEC

FY 2025

Mar 5, 2025·SEC

FY 2024

Mar 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 13, 2026·SEC

FY 2026

Aug 14, 2026·SEC

FY 2026

May 13, 2026·SEC

Get notified when SRTS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SRTS Frequently Asked Questions

Sensus Healthcare, Inc. (SRTS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Sensus Healthcare, Inc.'s revenue?

Sensus Healthcare, Inc. (SRTS) reported $16.6M in revenue over the trailing twelve months. Revenue was $27.5M in fiscal year 2025. That is 373% more than the $5.8M of fiscal year 2014.

How fast is Sensus Healthcare, Inc. growing?

Sensus Healthcare, Inc. (SRTS) revenue fell by 53.3% over the trailing twelve months, compared with the twelve months before.

Is SRTS profitable?

No. Sensus Healthcare, Inc. (SRTS) reported a net loss of $16.0M over the trailing twelve months.

Dividend & Returns
What is SRTS's return on equity?

Sensus Healthcare, Inc. (SRTS) had a return on equity (ROE) of -38.7% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Sensus Healthcare, Inc.'s free cash flow?

Sensus Healthcare, Inc. (SRTS) had negative free cash flow of $11.5M over the trailing twelve months.

What if you invested $1,000 in SRTS back in 2014?

Total return calculator · dividends reinvested · 12+ years of data

See returns →